(4-Piperazin-1-ylphenyl)boronic acid is an organic compound characterized by the presence of a boronic acid functional group attached to a phenyl ring that is further substituted with a piperazine moiety. This compound typically exhibits properties associated with both boronic acids and piperazine derivatives, including potential applications in medicinal chemistry and materials science. The boronic acid group allows for reversible interactions with diols, making it useful in various chemical reactions and as a building block in drug design. The piperazine ring contributes to its biological activity, often enhancing solubility and binding affinity in pharmacological contexts. Additionally, (4-piperazin-1-ylphenyl)boronic acid may exhibit moderate to high stability under standard conditions, although it can be sensitive to moisture and air due to the reactive nature of the boronic acid group. Its structural features suggest potential utility in the development of targeted therapies, particularly in the fields of oncology and neurology, where boron-containing compounds have shown promise.

(4-piperazin-1-ylphenyl)boronic acid

513246-99-6: (4-Piperazin-1-ylphenyl)boronic acid is an organic compound characterized by the presence of a boronic acid functional group attached to a phenyl ring that is further substituted with a piperazine moiety. This compound typically exhibits properties associated with both boronic acids and piperazine derivatives, including potential applications in medicinal chemistry and materials science. The boronic acid group allows for reversible interactions with diols, making it useful in various chemical reactions and as a building block in drug design. The piperazine ring contributes to its biological activity, often enhancing solubility and binding affinity in pharmacological contexts. Additionally, (4-piperazin-1-ylphenyl)boronic acid may exhibit moderate to high stability under standard conditions, although it can be sensitive to moisture and air due to the reactive nature of the boronic acid group. Its structural features suggest potential utility in the development of targeted therapies, particularly in the fields of oncology and neurology, where boron-containing compounds have shown promise.

CAS 513246-99-6

(4-piperazin-1-ylphenyl)boronic acid

4-(Piperazin-1-yl)phenylboronic acid

Ref: IN-DA00DKG3

4-(Piperazin-1-yl)phenylboronic acid

Ref: 54-OR361542

(4-(Piperazin-1-yl)phenyl)boronic acid

Ref: 10-F226080